|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|
| Cash Flows from Operating Activities | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to cash used in operating activities: | |
| Interest earned on securities held in Trust Account | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Deferred offering costs associated with proposed public offering | |
| Accounts payable to related party and accrued expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities | |
| Investments of cash in Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities | |
| Proceeds from sale of units and underwriter discounts | |
| Proceeds from sale of Private Placement Warrants | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash - beginning of the period | |
| Cash - end of the period | |
| Supplemental disclosure of noncash financing activities: | |
| Deferred offering cost in deferred underwriting compensation |
Loading...
